View in EDS PDF Full Text

MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.

Saved in:
Bibliographic Details
Title: MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
Authors: Jalali S; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.)., Chung C; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.)., Foltz W; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.)., Burrell K; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.)., Singh S; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.)., Hill R; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.)., Zadeh G; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).
Source: Neuro-oncology [Neuro Oncol] 2014 Jun; Vol. 16 (6), pp. 868-79. Date of Electronic Publication: 2014 Apr 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24759636
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jalali+S%22">Jalali S</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).<br /><searchLink fieldCode="AU" term="%22Chung+C%22">Chung C</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).<br /><searchLink fieldCode="AU" term="%22Foltz+W%22">Foltz W</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).<br /><searchLink fieldCode="AU" term="%22Burrell+K%22">Burrell K</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).<br /><searchLink fieldCode="AU" term="%22Singh+S%22">Singh S</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).<br /><searchLink fieldCode="AU" term="%22Hill+R%22">Hill R</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).<br /><searchLink fieldCode="AU" term="%22Zadeh+G%22">Zadeh G</searchLink>; Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada (S.J., K.B., S.S., G.Z.); Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (C.C., W.F.); Department of Radiation Oncology, University of Toronto, Toronto, Canada (W.F., R.H.); Ontario Cancer Institute, Princess Margaret Cancer Centre, and Department of Medical Biophysics, University of Toronto, Toronto, Canada (R.H.); Division of Neurosurgery, University of Toronto and Toronto Western Hospital, University Health Network, Toronto, Canada (G.Z.).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2014 Jun; Vol. 16 (6), pp. 868-79. <i>Date of Electronic Publication: </i>2014 Apr 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24759636
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/nou040
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 868
    Titles:
      – TitleFull: MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jalali S
      – PersonEntity:
          Name:
            NameFull: Chung C
      – PersonEntity:
          Name:
            NameFull: Foltz W
      – PersonEntity:
          Name:
            NameFull: Burrell K
      – PersonEntity:
          Name:
            NameFull: Singh S
      – PersonEntity:
          Name:
            NameFull: Hill R
      – PersonEntity:
          Name:
            NameFull: Zadeh G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2014 Jun
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1